Atos: contract to reinforce a supercomputer in Sweden | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-11 | 2024-09 | -0.05 | N/A | N/A | N/A |
2024-08-12 | 2024-06 | -0.05 | -0.05 | N/A | N/A |
2024-05-13 | 2024-03 | -0.07 | -0.05 | 0.02 | 28.57% |
2024-04-01 | 2023-12 | -0.05 | -0.06 | -0.01 | -20.00% |
2023-11-13 | 2023-09 | 0 | -0.05 | N/A | N/A |
2023-08-14 | 2023-06 | 0 | -0.06 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-07 | Cantor Fitzgerald | Upgrade | Overweight | |
2020-09-16 | Ascendiant Capital | Upgrade | Buy | |
2019-12-17 | Maxim Group | Upgrade | Hold | Buy |
2018-01-25 | Maxim Group | Upgrade | Buy | |
2013-10-06 | Sidoti & Co. | Downgrade | Buy | Neutral |
2013-04-14 | Sidoti & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2016-03-08 | CHEN SHU-CHIH | Director and Beneficial Owner of more than 10% of a Class of Security | 0.00 | Purchase |
2013-05-14 | CROSS ALEXANDER DENNIS | Director | 0.00 | Purchase |
2024-04-09 | FINN JONATHAN F. | Director | 25.00K | Purchase |
2017-11-14 | GUSE KYLE | General Counsel | 10.00K | Purchase |
2016-03-08 | QUAY STEVEN C | Chief Executive Officer | 0.00 | Purchase |
2017-04-16 | REMMEL H LAWRENCE | Director | 3.13K | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 5.68M | 7.15M | 4.51% |
2023-06-29 | Blackrock Inc. | 2.90M | 3.65M | 2.30% |
2023-06-29 | Laurion Capital Management, LP | 2.23M | 2.80M | 1.77% |
2023-06-29 | Geode Capital Management, LLC | 1.11M | 1.40M | 0.88% |
2023-06-29 | Renaissance Technologies, LLC | 1.07M | 1.35M | 0.85% |
2023-06-29 | State Street Corporation | 436.27K | 549.70K | 0.35% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 3.78M | 4.76M | 3.00% |
2023-06-29 | Vanguard Extended Market Index Fund | 1.66M | 2.10M | 1.32% |
2023-05-30 | Fidelity Extended Market Index Fund | 659.95K | 613.75K | 0.52% |
2023-05-30 | BlackRock Advantage Small Cap Core Fund | 340.50K | 316.67K | 0.27% |
2023-05-30 | Fidelity Total Market Index Fund | 182.91K | 170.11K | 0.15% |
2023-05-30 | Fidelity Series Total Market Index Fund | 142.17K | 132.22K | 0.11% |
Split | Date |
---|---|
1 : 12 | 2018-04-20 |
1 : 15 | 2016-08-26 |
-
When they don’t even have updates to provide that would have secured them $100 billion via the added shares, that tells you everything you need to know. Even the TUTES apparently voted NO.
Literally release ANY update prior to vote and it would have passed. $100 Billion missed out on because they had nothing to update on.
They simply have made no progress on anything.
-
There’s nothing to run this. Shorts will pull this down.
-
So shot down so badly by their Shareholders that they simply cancel the vote again. Lmmfao. What a shitshow. Of course Shareholders don’t want to approve massive dilution when you haven’t given them ANYTHING that remotely looks like you are making progress.
-
Relegated to repeating yourself now to try to feel better about the situation.
It’s plagued by shitty management with no regard to their shareholders.
They are trying to get one more fat payday to line their pockets with.
This is going under $2 after 100 million dilution.
-
Massive dilution coming for a stock that already gives zero updates to its investors.
Buy at $1.85 after dilution is approved.
-
So they are JUST NOW beginning to enroll for the clinical study in Sweden. Lmmfao, wasted an entire month doing jack shit. Now 6 more months minimum before you can even begin to expect the ENDOXIFIN results. Yet they want us to approve diluting the float by 100 million shares. How tf do you not see how crooked these mfers are? Do you see why Shorts love to drag this stock down? It’s because they know Quay is incompetent at managing a company.
-
There is no news because they have nothing to report. Nasal Spray is dead in the water. Quay wants that massive dilution because he knows that’s likely the last payday there will be.
-
Visit ATOSSA THERAPEUTICS on FB and enter yourself in the drawing, winner gets to name Quays new yacht he is about to buy after he dilutes this pos.
-
They bring it down, then will spike it up when it’s close to voting day to try to influence people to vote yes. Fucking criminals.
-
Yeah Pantras because you hate it being pointed out your predictions fall flat on their face every damn day.
Pivot Point your ass to people who ignore your daily failures. Eventually it’ll go up to 3.60 and you’ll beat your chest like you actually done something. Fucking moron
-
Pantras you predicting $4 today like you have every day for the past several weeks?
Pivot Point to dilution
-
Imagine someone citing SeekingAlpha as a valid source for stock price valuations, lmmfao. And simply because ATOS promises they won’t issue the new stock at less than $10 doesn’t make the value of the stock $10.
Of course the same guy constantly guaranteed $4 stock price every day the past two weeks. Take his Pivot Point analysis with a grain of salt. He’s literally throwing crap against the wall daily hoping it will stick. -
AstraZeneca is just yet another flimsy rumor. Quays dumbass probably don’t even know how to facilitate a buyout.
-
Pantras calling for $4 today again huh…more like $3.15
-
Up 4% on the day, down 10% for the week. Yah, Quay!!!!
-
$3.35 close
-
You can visit ATOSSA THERAPEUTICS on FB, be sure to congratulate Quay on his new yacht.
-
Yes, 3% gains on a week where it’s down 12% and down 24% the past two weeks. But I wouldn’t expect anything else from a group who blindly votes yes for massive dilution.
-
Up 2%, yaaahh!!!
-
Sweet, up 2% today, now only down 20% from last weeks $4.10…
-
Atos: contract to reinforce a supercomputer in Sweden
news.google.com •